$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000008611514000054 Filed on July 25, 2014

Income Statement

Concept	2014 Q2	2013 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.100M	$6.700M
YoY Change	-23.88%	31.37%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$5.100M	$6.700M
YoY Change	-23.88%	31.37%
Operating Profit	-$5.069M	-$6.715M
YoY Change	-24.51%	30.44%
Interest Expense	-$3.700M	-$18.70M
YoY Change	-80.21%	206.56%
% of Operating Profit
Other Income/Expense, Net	$1.452M	-$2.724M
YoY Change	-153.3%	-156.53%
Pretax Income	-$7.348M	-$28.12M
YoY Change	-73.87%	177.43%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.348M	-$28.12M
YoY Change	-73.87%	177.43%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.35	-$1.33
Diluted Earnings Per Share	-$0.35	-$1.33
COMMON SHARES
Basic Shares Outstanding	20.77M shares	21.13M shares
Diluted Shares Outstanding	20.77M shares	21.13M shares

Balance Sheet

Concept	2014 Q2	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$191.5M	$173.0M
YoY Change	10.69%	-14.44%
Cash & Equivalents	$164.5M	$102.7M
Short-Term Investments	$27.00M	$70.20M
Other Short-Term Assets	$1.500M	$1.300M
YoY Change	15.38%	-90.08%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$193.0M	$174.3M
YoY Change	10.7%	-19.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$110.0K	$164.0K
YoY Change	-32.93%	-18.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$121.7M	$102.7M
YoY Change	18.46%	-37.22%
Other Assets	$2.834M	$3.077M
YoY Change	-7.9%	-51.92%
Total Long-Term Assets	$151.2M	$161.8M
YoY Change	-6.57%	-8.89%
TOTAL ASSETS
Total Short-Term Assets	$193.0M	$174.3M
Total Long-Term Assets	$151.2M	$161.8M
Total Assets	$344.1M	$336.1M
YoY Change	2.39%	-14.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$272.0K	$203.0K
YoY Change	33.99%	1.5%
Accrued Expenses	$2.307M	$3.631M
YoY Change	-36.46%	-43.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$500.0K
YoY Change	-100.0%
Total Short-Term Liabilities	$4.954M	$7.938M
YoY Change	-37.59%	20.27%
LONG-TERM LIABILITIES
Long-Term Debt	$50.00M	$49.00M
YoY Change	2.04%	6.52%
Other Long-Term Liabilities	$3.522M	$3.862M
YoY Change	-8.8%	-3.45%
Total Long-Term Liabilities	$3.522M	$3.862M
YoY Change	-8.8%	-92.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.954M	$7.938M
Total Long-Term Liabilities	$3.522M	$3.862M
Total Liabilities	$58.49M	$60.77M
YoY Change	-3.76%	7.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$515.6M	-$544.1M
YoY Change	-5.24%
Common Stock	$825.2M	$819.5M
YoY Change	0.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$23.95M
YoY Change
Treasury Stock Shares	1.139M shares
Shareholders Equity	$285.7M	$275.3M
YoY Change
Total Liabilities & Shareholders Equity	$344.1M	$336.1M
YoY Change	2.39%	-14.45%

Cashflow Statement

Concept	2014 Q2	2013 Q2
OPERATING ACTIVITIES
Net Income	-$7.348M	-$28.12M
YoY Change	-73.87%	177.43%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$5.000M	-$4.600M
YoY Change	8.7%	58.62%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$12.90M	$30.40M
YoY Change	-142.43%	-205.56%
Cash From Investing Activities	-$13.00M	$30.40M
YoY Change	-142.76%	-205.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-17.40M	-100.0K
YoY Change	17300.0%	-125.0%
NET CHANGE
Cash From Operating Activities	-5.000M	-4.600M
Cash From Investing Activities	-13.00M	30.40M
Cash From Financing Activities	-17.40M	-100.0K
Net Change In Cash	-35.40M	25.70M
YoY Change	-237.74%	-181.85%
FREE CASH FLOW
Cash From Operating Activities	-$5.000M	-$4.600M
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$5.000M	-$4.600M
YoY Change	8.7%	58.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	272000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	245000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2431000	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2307000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	822103000	USD
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	823079000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1407000	USD
CY2013Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	1986000	USD
CY2014Q2	us-gaap	Advances To Affiliate AdvancesToAffiliate	5715000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1407000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	887000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1298000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	922000	USD
CY2013Q4	us-gaap	Assets Assets	345996000	USD
CY2014Q2	us-gaap	Assets Assets	344141000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	179130000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	192954000	USD
CY2013Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	15000	USD
CY2014Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	11000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164476000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139318000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102732000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66029000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	25158000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	36703000	USD
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21553000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21553000	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21573000	shares
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	2155000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7348000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-40062000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28123000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23971000	USD
CY2013Q4	us-gaap	Convertible Debt ConvertibleDebt	49948000	USD
CY2014Q2	us-gaap	Convertible Debt ConvertibleDebt	50009000	USD
CY2014Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2013Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	470000	USD
CY2014Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	50009000	USD
CY2013Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	49478000	USD
CY2014Q2	us-gaap	Cost Method Investments CostMethodInvestments	8468000	USD
CY2013Q4	us-gaap	Cost Method Investments CostMethodInvestments	15898000	USD
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.90
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.33
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.90
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.06
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5028000	USD
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2375000	USD
CY2014Q2	us-gaap	Equity Method Investments EquityMethodInvestments	121674000	USD
CY2013Q4	us-gaap	Equity Method Investments EquityMethodInvestments	110638000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5069000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12089000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6715000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10308000	USD
CY2014Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	26999000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7348000	USD
CY2013Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	38250000	USD
CY2013Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	6088000	USD
CY2014Q2	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	6896000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28123000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40062000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23971000	USD
CY2014Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3175000	USD
CY2013Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-18400000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3633000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-25387000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1074000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	2192000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	2143000	USD
CY2014Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1098000	USD
CY2013Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2014Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	2103000	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	542000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1524000	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	790000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1012000	USD
CY2013Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	148579000	USD
CY2014Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	135857000	USD
CY2014Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure	0	USD
CY2013Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure	20057000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	61335000	USD
CY2014Q2	us-gaap	Liabilities Liabilities	58485000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	344141000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	345996000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8174000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4954000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	49000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24904000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	48194000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	62840000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12778000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11540000	USD
CY2014Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-7348000	USD
CY2013Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-28123000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	26074000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-40062000	USD
CY2013Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	8135000	USD
CY2014Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	5479000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6715000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5069000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10308000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12089000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3911000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2834000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax	40000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax	26000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax	1000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax	4000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-40000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-26000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-4000	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3522000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3683000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	31826000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1967000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2724000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1452000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	8100000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	7618000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-6434000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-5000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25036000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	25406000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	15131000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	23874000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	29913000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	21000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2014Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1557000	USD
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1479000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	928000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	4097000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	81203000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	1403000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	573000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	92000	USD
	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	0	USD
	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	42000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	34444000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	92552000	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	-7348000	USD
	us-gaap	Profit Loss ProfitLoss	23971000	USD
	us-gaap	Profit Loss ProfitLoss	-40062000	USD
CY2013Q2	us-gaap	Profit Loss ProfitLoss	-28123000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	138000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	110000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	441000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	43000	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-515626000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-539597000	USD
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease	2200000	shares
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	29000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	51000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	573000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	25036000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	284661000	USD
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	285656000	USD
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	4000	shares
CY2014Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	1139000	shares
CY2014Q2	us-gaap	Treasury Stock Value TreasuryStockValue	23954000	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21128000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24653000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21119000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20771000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21226000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21119000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20771000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21128000	shares
CY2001Q4	sfe	Future Annual Payment To Chairman And Chief Executive Officer FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer	650000	USD
CY2014Q2	sfe	Partner Companies Not Consolidated In Financial Statements PartnerCompaniesNotConsolidatedInFinancialStatements	20	nonconsolidated_partner_company
CY2014Q2	sfe	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Award Vesting Types SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofAwardVestingTypes	3	vesting_type
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000086115
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20457170	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SAFEGUARD SCIENTIFICS INC
	dei	Trading Symbol TradingSymbol	SFE

Files In Submission

Name	View Source	Status
0000086115-14-000054-index-headers.html	Edgar Link	pending
0000086115-14-000054-index.html	Edgar Link	pending
0000086115-14-000054.txt	Edgar Link	pending
0000086115-14-000054-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20140630.xml	Edgar Link	completed
sfe-20140630.xsd	Edgar Link	pending
sfe-20140630_cal.xml	Edgar Link	unprocessable
sfe-20140630_def.xml	Edgar Link	unprocessable
sfe-20140630_lab.xml	Edgar Link	unprocessable
sfe-20140630_pre.xml	Edgar Link	unprocessable
sfe-2014xq2.htm	Edgar Link	pending
sfe-2014xq2ex322.htm	Edgar Link	pending
sfe-2014xq2xex311.htm	Edgar Link	pending
sfe-2014xq2xex312.htm	Edgar Link	pending
sfe-2014xq2xex321.htm	Edgar Link	pending
sfeex10x.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2014 Q2 Form 10-Q Financial Statement

#000008611514000054 Filed on July 25, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2014 Q2 Form 10-Q Financial Statement

#000008611514000054 Filed on July 25, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes